John A. Lewicki, EVP, Research & Development at OncoMed Pharmaceuticals Inc (OMED), sold 18,350 shares at $7.63 ($140K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $140k OMED by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.63 | 9,175 | $70K | 50.0% |
| 2 | $7.63 | 9,175 | $70K | 50.0% |
| Total | $7.63 avg | 18,350 | $140K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |